These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30142269)
1. In Silico Screening for Solid Dispersions: The Trouble with Solubility Parameters and χFH. Turpin ER; Taresco V; Al-Hachami WA; Booth J; Treacher K; Tomasi S; Alexander C; Burley J; Laughton CA; Garnett MC Mol Pharm; 2018 Oct; 15(10):4654-4667. PubMed ID: 30142269 [TBL] [Abstract][Full Text] [Related]
2. A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques. Chakravarty P; Lubach JW; Hau J; Nagapudi K Int J Pharm; 2017 Mar; 519(1-2):44-57. PubMed ID: 28063904 [TBL] [Abstract][Full Text] [Related]
3. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions. Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477 [TBL] [Abstract][Full Text] [Related]
4. COSMOPharm: Drug-Polymer Compatibility of Pharmaceutical Amorphous Solid Dispersions from COSMO-SAC. Antolović I; Vrabec J; Klajmon M Mol Pharm; 2024 Sep; 21(9):4395-4415. PubMed ID: 39078049 [TBL] [Abstract][Full Text] [Related]
5. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Marsac PJ; Shamblin SL; Taylor LS Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098 [TBL] [Abstract][Full Text] [Related]
6. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug. Mamidi HK; Rohera BD J Pharm Sci; 2021 Jul; 110(7):2703-2717. PubMed ID: 33609521 [TBL] [Abstract][Full Text] [Related]
7. Exploring the effect of hydrophilic and hydrophobic structure of grafted polymeric micelles on drug loading. Shi C; Sun Y; Wu H; Zhu C; Wei G; Li J; Chan T; Ouyang D; Mao S Int J Pharm; 2016 Oct; 512(1):282-291. PubMed ID: 27576669 [TBL] [Abstract][Full Text] [Related]
8. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Marsac PJ; Li T; Taylor LS Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927 [TBL] [Abstract][Full Text] [Related]
9. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System. Potter CB; Davis MT; Albadarin AB; Walker GM Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745 [TBL] [Abstract][Full Text] [Related]
11. Molecular modeling as a predictive tool for the development of solid dispersions. Maniruzzaman M; Pang J; Morgan DJ; Douroumis D Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898 [TBL] [Abstract][Full Text] [Related]
12. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions. Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671 [TBL] [Abstract][Full Text] [Related]
13. Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pisay M; Yarlagadda DL; Vullendula SKA; Bhat K; Kunnatur Balasundara K; Mutalik S Pharm Dev Technol; 2023 Feb; 28(2):176-189. PubMed ID: 36688412 [TBL] [Abstract][Full Text] [Related]
14. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Tian Y; Caron V; Jones DS; Healy AM; Andrews GP J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445 [TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory. Bansal K; Baghel US; Thakral S AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302 [TBL] [Abstract][Full Text] [Related]
16. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction. Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830 [TBL] [Abstract][Full Text] [Related]
17. Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories. Anderson BD J Pharm Sci; 2018 Jan; 107(1):24-33. PubMed ID: 29031973 [TBL] [Abstract][Full Text] [Related]
18. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium. Baghel S; Cathcart H; O'Reilly NJ Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287 [TBL] [Abstract][Full Text] [Related]
19. Prediction of drug-polymer miscibility through the use of solubility parameter based Flory-Huggins interaction parameter and the experimental validation: PEG as model polymer. Thakral S; Thakral NK J Pharm Sci; 2013 Jul; 102(7):2254-63. PubMed ID: 23649486 [TBL] [Abstract][Full Text] [Related]
20. Like Dissolves Like? A Comprehensive Evaluation of Partial Solubility Parameters to Predict Polymer-Drug Compatibility in Ultrahigh Drug-Loaded Polymer Micelles. Lübtow MM; Haider MS; Kirsch M; Klisch S; Luxenhofer R Biomacromolecules; 2019 Aug; 20(8):3041-3056. PubMed ID: 31318531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]